- Home
- COHR vs PCVX Comparison
COHR vs PCVX Comparison
Compare COHR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHR
- PCVX
- Stock Information
- Founded
- COHR 1971
- PCVX 2013
- Country
- COHR United States
- PCVX United States
- Employees
- COHR N/A
- PCVX N/A
- Industry
- COHR Electronic Components
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- COHR Technology
- PCVX Health Care
- Exchange
- COHR Nasdaq
- PCVX Nasdaq
- Market Cap
- COHR 16.1B
- PCVX 13.2B
- IPO Year
- COHR 1987
- PCVX 2020
- Fundamental
- Price
- COHR $104.96
- PCVX $88.68
- Analyst Decision
- COHR Strong Buy
- PCVX Strong Buy
- Analyst Count
- COHR 14
- PCVX 7
- Target Price
- COHR $106.93
- PCVX $147.50
- AVG Volume (30 Days)
- COHR 2.2M
- PCVX 1.1M
- Earning Date
- COHR 02-03-2025
- PCVX 11-05-2024
- Dividend Yield
- COHR N/A
- PCVX N/A
- EPS Growth
- COHR N/A
- PCVX N/A
- EPS
- COHR N/A
- PCVX N/A
- Revenue
- COHR $5,002,740,000.00
- PCVX N/A
- Revenue This Year
- COHR $20.51
- PCVX N/A
- Revenue Next Year
- COHR $11.53
- PCVX N/A
- P/E Ratio
- COHR N/A
- PCVX N/A
- Revenue Growth
- COHR 2.75
- PCVX N/A
- 52 Week Low
- COHR $40.12
- PCVX $53.83
- 52 Week High
- COHR $113.60
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- COHR 51.36
- PCVX 41.78
- Support Level
- COHR $101.23
- PCVX $86.80
- Resistance Level
- COHR $109.43
- PCVX $92.94
- Average True Range (ATR)
- COHR 4.37
- PCVX 3.22
- MACD
- COHR -0.37
- PCVX 0.44
- Stochastic Oscillator
- COHR 37.00
- PCVX 33.92
About COHR Coherent Corp.
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.